专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明专利

IL238631D0 A composition for treating diabetes or diabesity comprising oxyntomodulin analog 未知
公开(公告)号：IL238631D0
公开(公告)日：2015-06-30
申请号：IL23863115
申请日：2015-05-04
申请人： JUNG SUNG YOUB , KIM DAE JIN , HANMI PHARM IND CO LTD , KWON SE CHANG , KIM JIN SUN , LEE SANG HYUN
IPC分类号： A61K20060101
摘要： The present invention relates to a composition for preventing or treating diabetes, disbesity or diabetic complications, comprising an oxyntomodulin analog as an active ingredient. The invention also relates to a method for treating diabetes, diabesity or diabetic complications, comprising administering a pharmaceutically effective amount of an oxyntomodulin analog to a subject. The oxyntomodulin analog has a high ability to activate the GLP-1 receptor and the glucagon receptor, compared to native oxyntomodulin. The oxyntomodulin analog induces the expansion of beta-cells and increases insulin secretion, thereby reducing blood glucose levels that were increased due to a high-calorie and high-fat diet. The oxyntomodulin analog induces decreases in body weight and diet intake to improve insulin sensitivity and allow blood glucose levels, which are not controlled due to insulin resistance, to be maintained at normal levels. Thus, the oxyntomodulin analog can be effectively used to prevent or treat of diabetes and related diseases.

2. 发明专利

IL274106D0 Composition for treating hyperlipidemia comprising oxyntomodulin derivative 未知
公开(公告)号：IL274106D0
公开(公告)日：2020-06-30
申请号：IL27410620
申请日：2020-04-21
申请人： SUNG YOUB JUNG , IN YOUNG CHOI , HANMI PHARM IND CO LTD , KWON SE CHANG , KIM JIN SUN , JANG MYUNG HYUN , LEE SANG HYUN
发明人： SUNG YOUB JUNG , IN YOUNG CHOI , KWON SE CHANG , KIM JIN-SUN , JANG MYUNG HYUN , LEE SANG HYUN
IPC分类号： A61K38/22 , A61K38/26 , A61K45/06 , A61K47/59 , A61K47/60 , A61K47/64 , A61K47/68 , A61P1/16 , A61P3/00 , A61P3/04 , A61P3/06 , A61P3/10 , A61P9/10 , A61P31/14 , A61P31/20 , A61P43/00 , C07K14/605 , C07K14/76 , C07K14/78
摘要： The present invention relates to a composition for preventing or treating hyperlipidemia, fatty liver disease or arteriosclerosis, comprising an oxyntomodulin derivative as an active ingredient. The oxyntomodulin derivative has a high ability to activate GLP-1 receptor and glucagon receptor compared to native oxyntomodulin and has the effects of reducing the blood total cholesterol, low-density cholesterol and triglyceride levels that were increased by high-fat diet, and increasing high-density cholesterol levels and the high-density cholesterol/low-density cholesterol ratio. Thus, the oxyntomodulin derivative can be effectively used for the treatment of hyperlipidemia and related diseases.

3. 发明专利

IL238631A A composition for treating diabetes or diabesity comprising oxyntomodulin analog 未知
公开(公告)号：IL238631A
公开(公告)日：2020-04-30
申请号：IL23863115
申请日：2015-05-04
申请人： SUNG YOUB JUNG , KIM DAE JIN , HANMI PHARM IND CO LTD , KWON SE CHANG , KIM JIN SUN , LEE SANG HYUN
发明人： SUNG YOUB JUNG , KIM DAE JIN , KWON SE CHANG , KIM JIN-SUN , LEE SANG HYUN
IPC分类号： A61P3/10 , A61K38/26
摘要： The present invention relates to a composition for preventing or treating diabetes, disbesity or diabetic complications, comprising an oxyntomodulin analog as an active ingredient. The invention also relates to a method for treating diabetes, diabesity or diabetic complications, comprising administering a pharmaceutically effective amount of an oxyntomodulin analog to a subject. The oxyntomodulin analog has a high ability to activate the GLP-1 receptor and the glucagon receptor, compared to native oxyntomodulin. The oxyntomodulin analog induces the expansion of beta-cells and increases insulin secretion, thereby reducing blood glucose levels that were increased due to a high-calorie and high-fat diet. The oxyntomodulin analog induces decreases in body weight and diet intake to improve insulin sensitivity and allow blood glucose levels, which are not controlled due to insulin resistance, to be maintained at normal levels. Thus, the oxyntomodulin analog can be effectively used to prevent or treat of diabetes and related diseases.

4. 发明专利

IL236913D0 Composition for treating hyperlipidemia comprising oxyntomodulin derivative 未知
公开(公告)号：IL236913D0
公开(公告)日：2015-03-31
申请号：IL23691315
申请日：2015-01-25
申请人： SUNG YOUB JUNG , IN YOUNG CHOI , HANMI PHARM IND CO LTD , KWON SE CHANG , KIM JIN SUN , JANG MYUNG HYUN , LEE SANG HYUN
发明人： SUNG YOUB JUNG , IN YOUNG CHOI , KWON SE CHANG , KIM JIN-SUN , JANG MYUNG HYUN , LEE SANG HYUN
IPC分类号： A61K20060101
摘要： The present invention relates to a composition for preventing or treating hyperlipidemia, fatty liver disease or arteriosclerosis, comprising an oxyntomodulin derivative as an active ingredient. The oxyntomodulin derivative has a high ability to activate GLP-1 receptor and glucagon receptor compared to native oxyntomodulin and has the effects of reducing the blood total cholesterol, low-density cholesterol and triglyceride levels that were increased by high-fat diet, and increasing high-density cholesterol levels and the high-density cholesterol/low-density cholesterol ratio. Thus, the oxyntomodulin derivative can be effectively used for the treatment of hyperlipidemia and related diseases.

5. 发明专利

IL273305A A composition for treating diabetes or diabesity comprising oxyntomodulin analog 未知
公开(公告)号：IL273305A
公开(公告)日：2021-10-31
申请号：IL27330520
申请日：2020-03-15
申请人： HANMI PHARM IND CO LTD , SUNG YOUB JUNG , KIM DAE JIN , KWON SE CHANG , KIM JIN SUN , LEE SANG HYUN
发明人： SUNG YOUB JUNG , KIM DAE JIN , KWON SE CHANG , KIM JIN-SUN , LEE SANG HYUN
IPC分类号： A61K38/26 , A61K38/22 , A61K39/395 , A61K47/64 , A61P3/04 , A61P3/10 , C07K14/575 , C07K14/605 , C07K16/00 , C07K16/30
摘要： The present invention relates to a composition for preventing or treating diabetes, disbesity or diabetic complications, comprising an oxyntomodulin analog as an active ingredient. The invention also relates to a method for treating diabetes, diabesity or diabetic complications, comprising administering a pharmaceutically effective amount of an oxyntomodulin analog to a subject. The oxyntomodulin analog has a high ability to activate the GLP-1 receptor and the glucagon receptor, compared to native oxyntomodulin. The oxyntomodulin analog induces the expansion of beta-cells and increases insulin secretion, thereby reducing blood glucose levels that were increased due to a high-calorie and high-fat diet. The oxyntomodulin analog induces decreases in body weight and diet intake to improve insulin sensitivity and allow blood glucose levels, which are not controlled due to insulin resistance, to be maintained at normal levels. Thus, the oxyntomodulin analog can be effectively used to prevent or treat of diabetes and related diseases.

6. 发明专利

IL236913A Composition for treating hyperlipidemia comprising oxyntomodulin derivative 未知
公开(公告)号：IL236913A
公开(公告)日：2020-05-31
申请号：IL23691315
申请日：2015-01-25
申请人： SUNG YOUB JUNG , IN YOUNG CHOI , HANMI PHARM IND CO LTD , KWON SE CHANG , KIM JIN SUN , JANG MYUNG HYUN , LEE SANG HYUN
发明人： SUNG YOUB JUNG , IN YOUNG CHOI , KWON SE CHANG , KIM JIN-SUN , JANG MYUNG HYUN , LEE SANG HYUN
IPC分类号： A61K38/22 , A61K38/16 , A61K38/26 , A61K45/06 , A61P1/16 , A61P3/00 , A61P3/06 , A61P9/10
摘要： The present invention relates to a composition for preventing or treating hyperlipidemia, fatty liver disease or arteriosclerosis, comprising an oxyntomodulin derivative as an active ingredient. The oxyntomodulin derivative has a high ability to activate GLP-1 receptor and glucagon receptor compared to native oxyntomodulin and has the effects of reducing the blood total cholesterol, low-density cholesterol and triglyceride levels that were increased by high-fat diet, and increasing high-density cholesterol levels and the high-density cholesterol/low-density cholesterol ratio. Thus, the oxyntomodulin derivative can be effectively used for the treatment of hyperlipidemia and related diseases.

7. 发明专利

IL273305D0 A composition for treating diabetes or diabesity comprising oxyntomodulin analog 未知
公开(公告)号：IL273305D0
公开(公告)日：2020-04-30
申请号：IL27330520
申请日：2020-03-15
申请人： SUNG YOUB JUNG , KIM DAE JIN , HANMI PHARM IND CO LTD , KWON SE CHANG , KIM JIN SUN , LEE SANG HYUN
发明人： SUNG YOUB JUNG , KIM DAE JIN , KWON SE CHANG , KIM JIN-SUN , LEE SANG HYUN
IPC分类号： C07K20060101
摘要： The present invention relates to a composition for preventing or treating diabetes, disbesity or diabetic complications, comprising an oxyntomodulin analog as an active ingredient. The invention also relates to a method for treating diabetes, diabesity or diabetic complications, comprising administering a pharmaceutically effective amount of an oxyntomodulin analog to a subject. The oxyntomodulin analog has a high ability to activate the GLP-1 receptor and the glucagon receptor, compared to native oxyntomodulin. The oxyntomodulin analog induces the expansion of beta-cells and increases insulin secretion, thereby reducing blood glucose levels that were increased due to a high-calorie and high-fat diet. The oxyntomodulin analog induces decreases in body weight and diet intake to improve insulin sensitivity and allow blood glucose levels, which are not controlled due to insulin resistance, to be maintained at normal levels. Thus, the oxyntomodulin analog can be effectively used to prevent or treat of diabetes and related diseases.

8. 发明授权

KR101002900B1 Steel frame 无效
标题翻译：钢架
公开(公告)号：KR101002900B1
公开(公告)日：2010-12-21
申请号：KR20100087891
申请日：2010-09-08
申请人： CHUNG SE NAM , KIM JIN SUN
发明人： KIM JIN SUN , CHUNG SE NAM
IPC分类号： B23Q1/01 , B21D5/00 , B23Q1/03 , F16B7/00
摘要： PURPOSE: A steel frame is provided to uniformly disperse stress and reinforce strength despite external pressure, since the steel sheet is bent in multiple stages. CONSTITUTION: In a steel frame(10), a flat steel plate is bent into a square shape in multiple stages and is bisymmetrically formed. The still frame comprises a combining part(11), one or more recessed parts(12), and a center bent part(13). Both ends of the steel sheet are bent inward to reinforce strength. Both ends of the steel sheet form the combining parts. The combining parts support the anchoring bolt when being coupled with the joint member. The recessed parts, bearing lateral pressure, are formed on the side wall.
摘要翻译：目的：提供钢框架，以均匀地分散应力，并增强强度，尽管外部压力，因为钢板多次弯曲。构成：在钢框架（10）中，将平钢板多层弯曲成正方形并双向成形。静止框架包括组合部分（11），一个或多个凹陷部分（12）和中心弯曲部分（13）。钢板的两端向内弯曲以增强强度。钢板的两端形成组合部分。组合部件在与接头构件联接时支撑锚定螺栓。在侧壁上形成凹部，轴承侧压。

9. 发明公开

KR20090010447A BRUSHLESS FAN 无效
标题翻译：无刷风扇
公开(公告)号：KR20090010447A
公开(公告)日：2009-01-30
申请号：KR20070073552
申请日：2007-07-23
申请人： KIM JIN SUN , LEE JIN MIN
发明人： KIM JIN SUN , LEE JIN MIN
IPC分类号： F04D29/18 , F04D29/38
摘要： A brushless fan is provided to improve the torque efficiency through magnetic induction of the rotor in which a permanent magnet is connected between the rotating blades. A brushless fan comprises a rotor(100) in which a plurality of rotor poles(130) made of permanent magnet or iron material are formed, a stator(200) applying magnetic force by the external power supply to the rotor by including a magnetic induction core(220) inducing the magnetic force to the rotor pole, a rotor condition detection unit(400) sensing the location or rotation of the rotor, and a case(300) in which the rotor, the stator and the detection unit are mounted.
摘要翻译：提供无刷风扇以通过转子的磁感应来提高扭矩效率，其中永磁体连接在旋转叶片之间。无刷风扇包括：转子（100），其中形成有由永磁体或铁材料制成的多个转子极（130）;定子（200），其通过外部电源向转子施加磁力，包括磁感应感应转子极的磁力的转子状态检测单元（400）以及感应转子的位置或转动的转子状态检测单元（400）以及安装有转子，定子和检测单元的壳体（300）。

10. 发明授权

KR870001699B1 정유 페액의 처리장치 失效
公开(公告)号：KR870001699B1
公开(公告)日：1987-09-24
申请号：KR850001334
申请日：1985-03-04
申请人： KIM JIN SUN
发明人： KIM JIN-SUN
IPC分类号： C10G9/00 , C10G53/10

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式